BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

6699 related articles for article (PubMed ID: 3531448)

  • 1. Associated expression of HLA class I and class II antigens on melanoma cells in surgically removed metastases.
    van Duinen SG; Ruitter DJ; Ferrone S
    J Pathol; 1986 Aug; 149(4):339-48. PubMed ID: 3531448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective monomorphic and polymorphic HLA class I antigenic determinant loss in surgically removed melanoma lesions.
    Kageshita T; Ishihara T; Campoli M; Ferrone S
    Tissue Antigens; 2005 May; 65(5):419-28. PubMed ID: 15853896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Level of HLA antigens in locoregional metastases and clinical course of the disease in patients with melanoma.
    van Duinen SG; Ruiter DJ; Broecker EB; van der Velde EA; Sorg C; Welvaart K; Ferrone S
    Cancer Res; 1988 Feb; 48(4):1019-25. PubMed ID: 3338074
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of antigen-processing machinery and HLA antigen phenotype of melanoma cells with survival in American Joint Committee on Cancer stage III and IV melanoma patients.
    Anichini A; Mortarini R; Nonaka D; Molla A; Vegetti C; Montaldi E; Wang X; Ferrone S
    Cancer Res; 2006 Jun; 66(12):6405-11. PubMed ID: 16778219
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.
    Ruiter DJ; Bergman W; Welvaart K; Scheffer E; van Vloten WA; Russo C; Ferrone S
    Cancer Res; 1984 Sep; 44(9):3930-5. PubMed ID: 6204749
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Selective loss of human leukocyte class I allospecificities and staining of melanoma cells by monoclonal antibodies recognizing monomorphic determinants of class I human leukocyte antigens.
    Kageshita T; Wang Z; Calorini L; Yoshii A; Kimura T; Ono T; Gattoni-Celli S; Ferrone S
    Cancer Res; 1993 Jul; 53(14):3349-54. PubMed ID: 7686817
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC antigens in human melanomas.
    Ruiter DJ; Mattijssen V; Broecker EB; Ferrone S
    Semin Cancer Biol; 1991 Feb; 2(1):35-45. PubMed ID: 1912517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity of HLA-A,B, Ia-like, and melanoma-associated antigen expression by human melanoma cell lines analyzed with monoclonal antibodies and flow cytometry.
    Burchiel SW; Martin JC; Imai K; Ferrone S; Warner NL
    Cancer Res; 1982 Oct; 42(10):4110-5. PubMed ID: 7049355
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneous expression of melanoma-associated antigens and HLA antigens by primary and multiple metastatic lesions removed from patients with melanoma.
    Natali P; Bigotti A; Cavaliere R; Liao SK; Taniguchi M; Matsui M; Ferrone S
    Cancer Res; 1985 Jun; 45(6):2883-9. PubMed ID: 3157450
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface antigens of melanomas and melanocytes defined by mouse monoclonal antibodies: specificity analysis and comparison of antigen expression in cultured cells and tissues.
    Real FX; Houghton AN; Albino AP; Cordon-Cardo C; Melamed MR; Oettgen HF; Old LJ
    Cancer Res; 1985 Sep; 45(9):4401-11. PubMed ID: 4028024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HLA-G expression in malignant melanoma.
    Rebmann V; Wagner S; Grosse-Wilde H
    Semin Cancer Biol; 2007 Dec; 17(6):422-9. PubMed ID: 17689098
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant gamma-interferon induces changes in expression and shedding of antigens associated with normal human melanocytes, nevus cells, and primary and metastatic melanoma cells.
    Herlyn M; Guerry D; Koprowski H
    J Immunol; 1985 Jun; 134(6):4226-30. PubMed ID: 2985706
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of HLA class I and class II antigen expression and mortality in uveal melanoma.
    Ericsson C; Seregard S; Bartolazzi A; Levitskaya E; Ferrone S; Kiessling R; Larsson O
    Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2153-6. PubMed ID: 11527924
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotyping of lesions of melanocyte origin with monoclonal antibodies to melanoma-associated antigens and to HLA antigens.
    Natali PG; Bigotti A; Cavaliere R; Nicotra MR; Ferrone S
    J Natl Cancer Inst; 1984 Jul; 73(1):13-24. PubMed ID: 6376904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [An immunocytochemical investigation of antigen expression by skin melanoma cells cultured for vaccine production].
    Moiseenko VM; Danilova AB; Danilov AO; Turkevich EA; Baldueva IA; Matsko DE
    Vopr Onkol; 2008; 54(3):303-14. PubMed ID: 18652234
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lack of expression of HLA [corrected] class I and class II molecules on the human oocyte.
    Dohr GA; Motter W; Leitinger S; Desoye G; Urdl W; Winter R; Wilders-Truschnig MM; Uchanska-Ziegler B; Ziegler A
    J Immunol; 1987 Jun; 138(11):3766-70. PubMed ID: 3295039
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and genetic analysis of HLA class I and HLA-DR antigen expression on human melanomas.
    López-Nevot MA; Garcia E; Romero C; Oliva MR; Serrano S; Garrido F
    Exp Clin Immunogenet; 1988; 5(4):203-12. PubMed ID: 3078572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential modulation by recombinant immune interferon of the expression and shedding of HLA antigens and melanoma associated antigens by a melanoma cell line resistant to the antiproliferative activity of immune interferon.
    Ziai MR; Imberti L; Tongson A; Ferrone S
    Cancer Res; 1985 Nov; 45(11 Pt 2):5877-82. PubMed ID: 3931909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Methods in laboratory investigation. Immunoelectron microscopic methods for demonstration of antigens on normal human melanocytes and other epidermal cells.
    van Duinen SG; Mauw BJ; de Graaff-Reitsma CB; Ruiter DJ
    Lab Invest; 1984 Jun; 50(6):733-41. PubMed ID: 6427521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct mechanisms of loss of IFN-gamma mediated HLA class I inducibility in two melanoma cell lines.
    Rodríguez T; Méndez R; Del Campo A; Jiménez P; Aptsiauri N; Garrido F; Ruiz-Cabello F
    BMC Cancer; 2007 Feb; 7():34. PubMed ID: 17319941
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 335.